Parkin Protects against LRRK2 G2019S Mutant-Induced Dopaminergic Neurodegeneration in Drosophila
Open Access
- 9 September 2009
- journal article
- research article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 29 (36), 11257-11262
- https://doi.org/10.1523/jneurosci.2375-09.2009
Abstract
Mutations in theleucine-rich repeat kinase 2(LRRK2) gene are currently recognized as the most common genetic cause of parkinsonism. Among the large number of LRRK2 mutations identified to date, the G2019S variant is the most common. In Asia, however, another LRRK2 variant, G2385R, appears to occur more frequently. To better understand the contribution of different LRRK2 variants toward disease pathogenesis, we generated transgenicDrosophilaover-expressing various human LRRK2 alleles, including wild type, G2019S, Y1699C, and G2385R LRRK2. We found that transgenic flies harboring G2019S, Y1699C, or G2385R LRRK2 variant, but not the wild-type protein, exhibit late-onset loss of dopaminergic (DA) neurons in selected clusters that is accompanied by locomotion deficits. Furthermore, LRRK2 mutant flies also display reduced lifespan and increased sensitivity to rotenone, a mitochondrial complex I inhibitor. Importantly, coexpression of human parkin in LRRK2 G2019S-expressing flies provides significant protection against DA neurodegeneration that occurs with age or in response to rotenone. Together, our results suggest a potential link between LRRK2, parkin, and mitochondria in the pathogenesis of LRRK2-related parkinsonism.Keywords
This publication has 23 references indexed in Scilit:
- Kinase activity of mutant LRRK2 mediates neuronal toxicityNature Neuroscience, 2006
- Kinase activity is required for the toxic effects of mutant LRRK2/dardarinNeurobiology of Disease, 2006
- LRRK2G2019S as a Cause of Parkinson's Disease in North African ArabsThe New England Journal of Medicine, 2006
- Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degenerationProceedings of the National Academy of Sciences of the United States of America, 2005
- Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective functionHuman Molecular Genetics, 2005
- Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activityProceedings of the National Academy of Sciences of the United States of America, 2005
- Increased glutathione S -transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's diseaseProceedings of the National Academy of Sciences of the United States of America, 2005
- Chronic Exposure to Rotenone Models Sporadic Parkinson's Disease inDrosophila melanogasterJournal of Neuroscience, 2004
- Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's DiseaseNeuron, 2004
- Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic PathologyNeuron, 2004